Abstract: Provided are methods of treating a patient diagnosed with post-traumatic stress disorder, by administering to the patient a therapeutically effective amount of Compound A. Also provided are methods of improving resilience in a patient by administering a therapeutically effective amount of Compound A. Also provided are methods of diagnosing post-traumatic stress disorder in a patient by administering to the patient a therapeutically effective amount of Compound A and assessing at least one of sign, symptom, or symptom cluster of post-traumatic stress disorder; and diagnosing post-traumatic stress disorder in the patient if the Compound A reduces at least one of sign, symptom, and symptom cluster of post-traumatic stress disorder.

Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

Abstract: A storage router and related method are presented for combining multiple host frames, such as Fibre Channel frames, together into a single datagram for tunneling transmission over an IP or similar network. The storage router operates by storing incoming host frames in a host frame buffer. When there is sufficient data in the buffer, multiple host frames are batched together, compressed, and converted into an IP datagram. The number of host frames to be batched together can be established through a variety of tests, including total bytes of data, number of frames, or through a time-out mechanism. The network layer then fragments the datagram into data link level frames, such as 1500 byte Ethernet frames. When the datagram arrives at the final destination, the segmented datagram is reconstructed, decompressed, and the multiple host frames are then extracted and passed on to the recipient host frame network.

Abstract: Images are analyzed by programmatic mechanisms for accessing one or more remote web pages to retrieve content on display at the remote web pages. The retrieved images may be analyzed to determine information about an object shown in a corresponding image of the content on display. At least a portion of the object shown in the corresponding image of the content on display may be made selectable and associated with the determined information. This determined information may subsequently be used, in for example, search applications.

Abstract: A storage router and related method are presented for combining multiple Fibre Channel frames together into a single IP datagram for tunneling transmission over an Internet protocol network. The storage router operates by storing incoming Fibre Channel frames in a Fibre Channel frame buffer. When there is sufficient data in the buffer, multiple Fibre Channel frames are taken from the buffer and combined into a single IP datagram. The number of Fibre Channel frames to be combined can be established through a variety of tests, including total bytes of data, number of frames, or through a time-out mechanism. The network layer then fragments the datagram into data link level frames, such as 1500 byte Ethernet frames. When the IP datagram arrives at the final destination, the segmented IP datagram is reconstructed, and the multiple Fibre Channel frames are extracted from the IP datagram and passed on to the recipient Fibre Channel network.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.

Abstract: A storage router and related method are presented for combining multiple host frames, such as Fibre Channel frames, together into a single datagram for tunneling transmission over an IP or similar network. The storage router operates by storing incoming host frames in a host frame buffer. When there is sufficient data in the buffer, multiple host frames are batched together, compressed, and converted into an IP datagram. The number of host frames to be batched together can be established through a variety of tests, including total bytes of data, number of frames, or through a time-out mechanism. The network layer then fragments the datagram into data link level frames, such as 1500 byte Ethernet frames. When the datagram arrives at the final destination, the segmented datagram is reconstructed, decompressed, and the multiple host frames are then extracted and passed on to the recipient host frame network.

Abstract: A new polymorphic form of (±)7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid is disclosed. The compound has a melting point of 80° C. to 82° C. and is a leukotriene B4 antagonist (“LBA”). The compound is useful for diminishing the adverse effects (e.g. vascular leakage syndrome) of IL-2 treatment.

Abstract: The present invention relates to a device for use in maintaining a temperature in a vehicle or a shipping container. The device includes a roller having a sheet attached to the roller. One end of the sheet is connected to the roller and the sheet can be rolled around the roller and unrolled from the roller. The sheet has a size such that the sheet can extend substantially transversely across the cargo area of the vehicle or shipping container when the device is mounted on the vehicle or shipping container and the sheet is unrolled from the roller. The device allows for a user to simply unroll the unattached end of the sheet from the roller when the user needs to load or unload goods in the cargo area of the vehicle or shipping container in which the device is mounted.

Abstract: The present invention relates to a device for use in maintaining a temperature in a vehicle or a shipping container. The device includes a roller having a sheet attached to the roller. One end of the sheet is connected to the roller and the sheet can be rolled around the roller and unrolled from the roller. The sheet has a size such that the sheet can extend substantially transversely across the cargo area of the vehicle or shipping container when the device is mounted on the vehicle or shipping container and the sheet is unrolled from the roller. The device allows for a user to simply unroll the unattached end of the sheet from the roller when the user needs to load or unload goods in the cargo area of the vehicle or shipping container in which the device is mounted.

Abstract: A storage router and related method are presented for combining multiple host frames, such as Fibre Channel frames, together into a single datagram for tunneling transmission over an IP or similar network. The storage router operates by storing incoming host frames in a host frame buffer. When there is sufficient data in the buffer, multiple host frames are batched together, compressed, and converted into an IP datagram. The number of host frames to be batched together can be established through a variety of tests, including total bytes of data, number of frames, or through a time-out mechanism. The network layer then fragments the datagram into data link level frames, such as 1500 byte Ethernet frames. When the datagram arrives at the final destination, the segmented datagram is reconstructed, decompressed, and the multiple host frames are then extracted and passed on to the recipient host frame network.

Abstract: A method of treating an immunologic, proliferative, or infectious disease in a warm-blooded animal is disclosed. The method comprises administering to the animal omega interferon (IFN) at a dosage and activity for the disease state treated sufficient to induce a therapeutic response in the animal, which dosage and activity for the disease state treated is higher than would be well-tolerated based on data for non-omega IFN's. The omega IFN is administered alone or in combination with a therapeutically effective amount of at least one adjunctive therapeutic agent. Also disclosed is an article of manufacture useful for treating an immunologic, proliferative, or infectious disease, which article comprises (1) omega IFN in a form suitable for administering a therapeutically effective amount of the omega IFN to the subject in order to induce the desired therapeutic response (2) instructions for administering the omega IFN as desired, that is higher than would be well-tolerated based on data for non-omega IFNs.

Abstract: A storage router and related method are presented for combining multiple Fibre Channel frames together into a single IP datagram for tunneling transmission over an Internet protocol network. The storage router operates by storing incoming Fibre Channel frames in a Fibre Channel frame buffer. When there is sufficient data in the buffer, multiple Fibre Channel frames are taken from the buffer and combined into a single IP datagram. The number of Fibre Channel frames to be combined can be established through a variety of tests, including total bytes of data, number of frames, or through a time-out mechanism. The network layer then fragments the datagram into data link level frames, such as 1500 byte Ethernet frames. When the IP datagram arrives at the final destination, the segmented IP datagram is reconstructed, and the multiple Fibre Channel frames are extracted from the IP datagram and passed on to the recipient Fibre Channel network.

Abstract: Disclosed are methods and compositions for treating proliferative disorders, such as cancers, blood vessel disorders, fibrotic disorders and acute or chronic rejection of transplanted organs, tissue or cells, using compounds of formula I or a tautomeric isomer thereof: wherein R1 and R2 are as defined; or a pharmaceutically-acceptable salt or pro-drug thereof.

Abstract: Methods for the treatment of interferon-response disorders by administration of an interferon alone or in combination with adjunctive therapy are described. The invention encompasses providing to a patient both a formulation of an interferon that is suitable for short-term administration and a formulation of an interferon associated with a sustained release delivery system that is suitable for long-term administration. A principal advantage of the method is that responsiveness to treatment can be ascertained with short-term dosimetric techniques using one formulation of an interferon, which permits the appropriate selection of a dose that is both effective and safe for long-term administration using the second formulation.

Abstract: A method and composition for preserving or enhancing the beneficial effects of interleukin-2 (IL-2) while simultaneously mitigating the adverse effects of IL-2 on a subject is disclosed. The method involves administering an amount of a leukotriene B4 (LTB4) antagonist, preferably a LTB4 receptor antagonistic, to a subject exhibiting adverse pharmacological effects due to exogenous IL-2, where the amount administered to the subject is sufficient to decrease the IL-2 induces adverse effects. Also disclosed is an article of manufacturing comprising a composition of the leukotriene B4 antagonist in combination with labeling instructions for treatment. Also disclosed is a method for preparing a pharmaceutical composition. Generally the LTB4 antagonist will reduce the IL-2-induced adverse effects while preserving or enhancing the antitumor, antiviral, or immunostimulatory effects of IL-2, thereby improving the therapeutic index of IL-2.